Kelly Ascencao

Title: Kelly Ascencao: Innovator in Kinase Mutants

Introduction

Kelly Ascencao is a prominent inventor based in Prilly, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the design and application of kinase mutants. Her innovative work focuses on enhancing the sensitivity of target kinases to specific inhibitors, which has important implications for cancer treatment.

Latest Patents

Kelly Ascencao holds a patent titled "Kinase mutants and uses thereof." This invention relates to methods for designing kinase mutants that can be reprogrammed to respond to specific inhibitors. These inhibitors have little or no affinity for the wild-type target kinase. The patent also covers vectors or cells expressing these mutated kinases, along with compositions and uses for the prevention and treatment of diseases, particularly cancer.

Career Highlights

Throughout her career, Kelly has worked with esteemed organizations such as the Swiss Institute of Bioinformatics and the Centre Hospitalier Universitaire Vaudois. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kelly has collaborated with notable colleagues, including Olivier Michielin and Vincent Zoete. Their combined expertise has further advanced the research and applications of kinase mutants.

Conclusion

Kelly Ascencao is a trailblazer in the field of biotechnology, with her innovative patent on kinase mutants paving the way for new cancer treatments. Her work exemplifies the impact of scientific research on healthcare advancements.